ADVA
ADVA (FSE: ADV) today announced the Cyprus Telecommunications Authority (Cyta) is leveraging its timing technology in a national synchronization network, addressing legacy timing applications and ensuring a smooth migration to precise packet timing for 5G critical services in the future. The solution enables Cyta to meet the stringent timing requirements of next-generation services while supporting all existing mobile technologies. ADVA’s Oscilloquartz PTP grandmaster clock and GNSS receiver technology not only enhances synchronization precision but also provides new levels of resilience and reliability. The project was facilitated by ADVA’s partners, the ICT solutions providers GCC Computers Ltd and ADAPTIT S.A., which will also provide ongoing technical support.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210713005088/en/
“Cyta now has a synchronization network able to address the accuracy, efficiency and stability demands of 5G. With support for NTP, PTP and SyncE, our technology ensures that the new infrastructure meets the needs of Cyta’s legacy applications, ensuring a smooth migration to the precise packet timing that is critical for 5G services,” said Hartmut Müller-Leitloff, SVP, sales, EMEA, ADVA. “Together with GCC’s and ADAPTIT S.A.’s teams, we’ve engineered a solution that fits Cyta’s exact requirements. It provides the sub-microsecond accuracy necessary for advanced mobile applications together with hardware redundancy for unbeatable resilience. What’s more, our Ensemble Controller network management technology makes it simple to operate.”
Prior to the deployment, Cyta’s timing network was based purely on frequency synchronization. It now distributes stable and accurate phase and time-of-day information, supporting the enhanced spectrum utilization needed for 5G. The solution features the OSA 5420 Series of grandmaster clocks, optimized for mobile backhaul and fronthaul in the radio access network. In the core, the OSA 5440 provides highest accuracy and availability with its dual multi-band, multi-constellation GNSS receiver and full hardware redundancy. The technology is remotely controlled by ADVA’s Ensemble Sync Director. This provides a powerful management platform, giving Cyta full visibility of its synchronization infrastructure and assuring perfect end-to-end timing.
“We’ve worked closely with Cyta to create a synchronization solution that fits its precise needs. Able to support both legacy and next-generation packet networking, Cyta’s new timing network is space- and power-efficient, assured by in-service PTP and GNSS monitoring and protected by hardware redundancy. Our engineers have also provided support at every stage of the process and made certain that the installation was carried out without any disruption to services,” commented Vasileios Karavasilis, commercial director, ADAPTIT S.A. “As a key distributor of ADVA’s Oscilloquartz solutions, we know all about the value of precise and reliable timing in mission-critical networks. Cyta is now prepared for mass 5G rollout with a synchronization architecture able to meet key challenges both now and in the future.”
About ADVA
ADVA is a company founded on innovation and focused on helping our customers succeed. Our technology forms the building blocks of a shared digital future and empowers networks across the globe. We’re continually developing breakthrough hardware and software that leads the networking industry and creates new business opportunities. It’s these open connectivity solutions that enable our customers to deliver the cloud and mobile services that are vital to today’s society and for imagining new tomorrows. Together, we’re building a truly connected and sustainable future. For more information on how we can help you, please visit us at www.adva.com .
About Oscilloquartz
Oscilloquartz is a pioneer in time and frequency synchronization. We design, manufacture and deploy end-to-end synchronization systems that ensure the delivery and assurance of highly precise timing information over next-generation packet and legacy networks. As an ADVA company, we’re creating new opportunities for tomorrow’s networks. For more information, please visit us at www.oscilloquartz.com .
About GCC Computers Ltd.
GCC Computers has a distinguished market presence in Cyprus as an ICT System Integrator and has built a strong reputation as the employer of the best technology professionals. For more than 30 years, GCC has been acknowledged with considerable success serving Public/Government, Telecommunications & Utilities, Banking/Finance and SME (Small-Medium-Enterprise) sectors with innovative solutions. GCC’s expertise and extensive partnerships help clients harness the technology power to thrive on change and guide their digital transformation journeys. For more information, please visit us at www.gcc.com.cy .
About ADAPTIT S.A.
ADAPTIT S.A. is a highly specialized System Integrator that combines latest technology trends to offer its clients innovative tailor-made solutions, according to their needs, and finally delivers high-quality TURNKEY PROJECTS, ensuring the highest possible performance of their investment. With a wide-range portfolio of networking solutions ADAPTIT provides networking expertise to Service Providers, Government Agencies and Enterprises. ADAPTIT S.A. has presence in most European countries, having delivered similar major projects to several Service Providers in Spain, Sweden, Finland, Portugal, Poland, Romania, Malta, Bulgaria, and Albania. For more information, please visit us at www.adaptit.gr .
About Cyta
Cyta is the leading provider of integrated electronic communications in Cyprus. Making the most of its technologically advanced networks, it offers a wide range of services and solutions to meet the ever-increasing demands of its residential and business customers for voice, data and content applications. With a pivotal role in the digital transformation of Cyprus, Cyta is deploying an island-wide, fiber-optic network, while it progressively upgrades its mobile network technology. It advances and maintains subsea and satellite networks for international connections of strategic importance that have established Cyprus as a regional telecommunications and connectivity hub in the Eastern Mediterranean. www.cyta.com.cy
Published by:
ADVA Optical Networking SE, Munich, Germany
www.adva.com
View source version on businesswire.com: https://www.businesswire.com/news/home/20210713005088/en/
Social Media:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
NHOA Energy Achieves Great Place To Work Certification in Italy, the United States and Australia18.12.2025 10:53:00 CET | Press release
NHOA Energy, global provider of utility-scale energy storage systems, announces that it has been certified Great Place To Work® in Italy, the United States, and Australia. The certification is based entirely on direct feedback from NHOA Energy employees, gathered through an independent and structured listening process. Great Place To Work® Certification™ assesses the quality of the employee experience across key dimensions such as credibility, respect, fairness, pride, and camaraderie. The results achieved by NHOA Energy reflect a corporate culture built on trust, inclusion, and the consistent commitment to valuing people within a dynamic and international environment. Employees highlighted particularly high levels of appreciation for the ethical and transparent behavior of leaders, the welcoming and inclusive approach toward new hires, and fair treatment across diversity, equity, and inclusion dimensions. A strong majority also expressed pride in working at NHOA Energy and reported a
Regnology Signs an Agreement to Acquire Moody’s Regulatory Reporting & ALM Solutions18.12.2025 10:00:00 CET | Press release
The deal further strengthens Regnology’s global position in Regulatory Reporting and significantly accelerates its expansion into new markets Regnology, a leading provider in regulatory, risk, tax, and finance reporting, as well as supervisory technology, today announced it has signed an exclusive agreement for the acquisition of Moody’s Regulatory Reporting & ALM Solutions business, inclusive of solutions for Basel III compliance, IFRS9 impairment accounting, large bank asset-liability management (ALM), Solvency II insurance reporting, and prudential and statistical regulatory reporting across more than 50 jurisdictions. By integrating Moody’s regulatory capital and liquidity capabilities with Regnology’s regulatory, risk, and finance offerings, the firm is creating a unified, scalable platform designed to meet the full spectrum of financial regulatory compliance and risk requirements. This combined strength positions Regnology as the partner of choice for financial institutions seeki
Reply Recognized as a Microsoft Azure Expert Managed Services Provider for the Sixth Consecutive Year18.12.2025 10:00:00 CET | Press release
Reply [EXM, STAR: REY] announced today it has been recognized once again as a Microsoft Azure Expert Managed Services Provider (MSP). The renewal reaffirms Reply’s proven expertise and consistent track record in delivering high-quality cloud solutions and services on the Microsoft Azure platform, powered by the deep technical expertise of its specialized companies – Cluster Reply, Solidsoft Reply and Valorem Reply. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251218596617/en/ This recognition reflects the ongoing collaboration between Reply - through its companies Cluster Reply, Solidsoft Reply, and Valorem Reply - and Microsoft, supporting shared efforts to deliver value-driven services to enterprise customers. The Azure Expert MSP program is designed by Microsoft to identify and validate partners with proven capabilities in delivering end-to-end Azure services at scale. To qualify, partners must meet a strict set of requ
Takeda’s Zasocitinib Landmark Phase 3 Plaque Psoriasis Data Show Promise to Deliver Clear Skin in a Once-Daily Pill, Catalyzing a New Era of Treatment18.12.2025 09:00:00 CET | Press release
Pivotal Phase 3 studies of once-daily oral zasocitinib met all primary and ranked secondary endpoints in patients with moderate-to-severe plaque psoriasis More than half of study participants treated with zasocitinib achieved clear or almost clear skin (PASI 90), and on average about 30 percent achieved completely clear skin (PASI 100) by week 16 Zasocitinib was generally well-tolerated with a safety profile consistent with previous clinical studies Takeda(TSE:4502/NYSE:TAK)today announced positive topline results for the two pivotal Phase 3randomized, multicenter, double-blind, placebo- and active comparator-controlled studies of zasocitinib (TAK-279), a next-generation, highly selective oral tyrosine kinase 2 (TYK2) inhibitor, in adults with moderate-to-severe plaque psoriasis (PsO). The studies demonstrated superiority of zasocitinib compared to placebo for the co-primary endpoints, static Physician Global Assessment (sPGA) 0/1 and Psoriasis Area and Severity Index (PASI) 75, at wee
DATROWAY® Type II Variation Application Validated in the EU as First-Line Treatment for Patients with Metastatic Triple Negative Breast Cancer Who are Not Candidates for Immunotherapy18.12.2025 08:30:00 CET | Press release
Based on TROPION-Breast02 phase 3 trial results where Daiichi Sankyo and AstraZeneca’s DATROWAY is the first and only medicine to significantly improve overall survival versus chemotherapy in this patient population If approved, DATROWAY could become the standard of care in this setting The European Medicines Agency (EMA) has validated the Type II Variation marketing authorization application for DATROWAY® (datopotamab deruxtecan) as monotherapy for the first-line treatment of adult patients with unresectable or metastatic triple negative breast cancer (TNBC) who are not candidates for PD-1/PD-L1 inhibitor therapy. DATROWAY is a specifically engineered TROP2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/Nasdaq: AZN). The validation confirms the completion of the application and commences the scientific review process by the EMA’s Committee for Medicinal Produc
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom